The advertising techniques they used were all enlightening. These of course are all deceptive. Starting NuvaRing is not going to have men serving you drinks by the pool. In another advertisement, on their website, nuvaring. Those things just so happen to be a puppy and some groceries, which in my opinion is promoting the gender stereotype that women belong in the kitchen.
But after using NuvaRing, the women is seen meditating, she is now mindful and at peace, filled with blue skies and lotus flowers. To be completely honest, I have a pretty neutral opinion on the drug. I have heard success stories and horror stories from women who have used this drug. For some people it is very convenient and works really well for them. For others, they experience horrible side effects, and for a select few, they even faced death.
I think deciding to use this drug all depends on personal preference and what you think is best for you. Kaye, R. Families, lawsuits, raise questions about NuvaRing. How NuvaRing Works.
NuvaRing is the trade name for a vaginal ring combined hormonal contraceptive manufactured by Organon that is available by prescription. It is a flexible plastic ring that releases a low dose of a progestin and an estrogen over 3 weeks.
NuvaRing is currently used by approximately 1. The currently approved NuvaRing regimen specifies insertion of the ring into the vagina for a three-week period, then removal of the ring for one week, during which the user will experience a menstrual period.
The break week with NuvaRing is comparable to the placebo week for combined oral contraceptive pills "the Pill" , and the contraceptive effect is maintained during this period. Extended use regimens 7-week, quarterly, or annual involving back-to-back use of 2, 4, or 17 rings have been studied in clinical trials, but are not currently approved. Insertion of the ring is comparable to insertion of other vaginal rings.
The muscles of the vagina keep NuvaRing securely in place, even during exercise or sex. Women can check the contraceptive ring periodically with their finger. In rare instances, NuvaRing may fall out during sexual intercourse, while straining during a bowel movement, or while removing a tampon. Contraceptive efficacy is not reduced if the ring is removed or accidentally expelled and is left outside of the vagina for less than three hours. If the ring has been out of the vagina for more than three continuous hours, contraceptive efficacy may be reduced and a backup method of contraception must be used until the ring has been used continuously for a subsequent seven days.
In two large studies, over a one year period, Device-related adverse events foreign body sensation, coital problem, or expulsion were the most frequently reported adverse events that resulted in discontinuation by 2. Device-related adverse events were reported at least once during the one year study period by 4. Etonogestrel , the specific progestin used in NuvaRing, is the active metabolite of the inactive prodrug desogestrel , one of two third-generation progestins found in some epidemiological studies of combined oral contraceptive pills to be associated with a higher risk of venous thrombosis than combined oral contraceptive pills containing certain second-generation progestins.
Because hormones are released continuously from NuvaRing, peak and total estrogen and progestin doses are significantly lower than with combined oral contraceptives, although it is not known whether this lowers the risk of blood clots.
Like all combined hormonal contraceptives, NuvaRing works primarily by preventing ovulation. A secondary mechanism of action is inhibition of sperm penetration by changes in the cervical mucus.
Hormonal contraceptives also have effects on the endometrium that theoretically could affect implantation, however no scientific evidence indicates that prevention of implantation actually results from their use.
A vaginal ring for HIV prevention that slowly releases the antiretroviral drug dapivirine is being developed. A study design in which patients receive routine clinical care and researchers record the outcome.
Observational studies can provide useful information but are considered less reliable than experimental studies such as randomised controlled trials. Some examples of observational studies are cohort studies and case-control studies. The World Bank classifies countries according to their income: low, lower-middle, upper-middle and high.
There are around 50 lower-middle income countries mostly in Africa and Asia and around 60 upper-middle income countries in Africa, Eastern Europe, Asia, Latin America and the Caribbean.
Many people find this term stigmatising as it suggests information which is normally kept secret. In pharmacology, a medication which maintains its effects over a long period of time, such as an injection or implant. Dr Jennifer Griffin of RTI International and colleagues conducted this systematic review to assess the acceptability of the vaginal ring and related preferences, among women in low- and middle-income countries, to inform further investment and guidance on vaginal rings for HIV prevention.
They analysed 47 studies, including 14 randomised controlled trials and 33 observational studies, published between and Qualitative studies were excluded. The studies included women over 15 years of age and were conducted in 25 low- and middle-income countries, with most studies from Asia 17 and sub-Saharan Africa Most of the studies were of vaginal rings for contraception 28 , followed by HIV prevention 10 , multipurpose prevention technologies 4 , abnormal uterine bleeding 3 , pelvic pain 1 and menopause symptom management 1.
0コメント